163 related articles for article (PubMed ID: 6611204)
1. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
[TBL] [Abstract][Full Text] [Related]
2. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
[TBL] [Abstract][Full Text] [Related]
3. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
Valone FH; Kohler M; Fisher K; Hannigan J; Flam M; Gandara D; Hendrickson C; Richman E; Yu KP
NCI Monogr; 1987; (5):175-7. PubMed ID: 2963230
[TBL] [Abstract][Full Text] [Related]
4. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
[TBL] [Abstract][Full Text] [Related]
5. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer.
Sobrero A; Frassineti G; Falcone A; Dogliotti L; Rosso R; Di Costanzo F; Bruzzi P;
Br J Cancer; 2005 Jan; 92(1):24-9. PubMed ID: 15611795
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 9603 Trial.
Yamao T; Shimada Y; Shirao K; Ohtsu A; Ikeda N; Hyodo I; Saito H; Iwase H; Tsuji Y; Tamura T; Yamamoto S; Yoshida S
Jpn J Clin Oncol; 2004 Jun; 34(6):316-22. PubMed ID: 15333683
[TBL] [Abstract][Full Text] [Related]
8. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
[TBL] [Abstract][Full Text] [Related]
9. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical modulation with sequential methotrexate (MTX)-5-fluorouracil (5-FU) treatment].
Ota K; Murakami M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1642-9. PubMed ID: 3496047
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of sequential methotrexate and 5-fluorouracil chemotherapy in previously treated gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group, JCOG 9207 trial.
Hamaguchi T; Shirao K; Yamamichi N; Hyodo I; Koizumi W; Seki S; Imamura T; Honma H; Ohtsu A; Boku N; Mukai T; Yamamoto S; Fukuda H; Yoshida S;
Jpn J Clin Oncol; 2008 Jun; 38(6):432-7. PubMed ID: 18515821
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of sequential methotrexate and 5-FU combination in the treatment of advanced colorectal cancer.
Canobbio L; Nobile MT; Ardizzoni A; Tatarek R; Rosso R
Cancer Treat Rep; 1986 Mar; 70(3):419-20. PubMed ID: 3955557
[No Abstract] [Full Text] [Related]
13. Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Tixi LM; Bolli EA; Rosso R; Mammoliti S; Rollandi GA; Bertoglio S
Clin Cancer Res; 1995 Sep; 1(9):955-60. PubMed ID: 9816066
[TBL] [Abstract][Full Text] [Related]
14. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
[TBL] [Abstract][Full Text] [Related]
15. Sequential methotrexate and 5-FU in the treatment of colorectal cancer.
Weinerman B; Schacter B; Schipper H; Bowman D; Levitt M
Cancer Treat Rep; 1982 Jul; 66(7):1553-5. PubMed ID: 6980048
[TBL] [Abstract][Full Text] [Related]
16. Postsurgical sequential methotrexate/5-FU and leucovorin on outpatient basis for advanced colorectal carcinoma.
Tokunaga Y; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
Hepatogastroenterology; 2001; 48(37):128-32. PubMed ID: 11268947
[TBL] [Abstract][Full Text] [Related]
17. Palliative chemotherapy in metastatic colorectal carcinoma: comparison of two chemotherapeutic regimens.
Bremnes RM; Wist EA
Anticancer Res; 1996; 16(2):921-6. PubMed ID: 8687152
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
[TBL] [Abstract][Full Text] [Related]
19. Biomodulation of 5-fluorouracil with antifolates.
Bertino JR
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-52-S18-56. PubMed ID: 9420021
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of sequential methotrexate-5-FU therapy in advanced measurable colorectal cancer.
Cantrell JE; Brunet R; Lagarde C; Schein PS; Smith FP
Cancer Treat Rep; 1982 Jul; 66(7):1563-5. PubMed ID: 7093972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
